Product image of Liana (Ethinylestradiol, Levonorgestrel) supplied by GNH India

Liana

Active Ingredient:
Ethinylestradiol, Levonorgestrel
Origin:
EU

Liana (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol and Levonorgestrel, the active ingredients in Liana, are a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation, altering cervical mucus, and changing the endometrial lining to prevent implantation.

GNH India supplies Liana as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent product quality for global contraceptive programs, and ensuring timely delivery to end‑users across diverse regions.

Manufacturer / TM Owner

Ratiopharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Liana, a combined oral contraceptive, is used to prevent pregnancy by modulating the hormonal axis.
  • Contraception: Prevents pregnancy by suppressing ovulation and altering cervical mucus.
  • Menstrual cycle regulation: Helps establish regular menstrual bleeding patterns.
  • Acne treatment: Reduces androgen‑driven acne in women when prescribed for this indication.

How It Works

  • Ethinylestradiol and levonorgestrel act synergistically to inhibit the hypothalamic‑pituitary‑ovarian axis, reducing the secretion of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH). This suppression prevents follicular development and ovulation. In addition, the progestogenic component thickens cervical mucus and the estrogen component stabilizes the endometrial lining, creating an environment unfavorable for implantation.

Side Effects

Liana may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like pain.
  • Breast tenderness: discomfort or swelling of the breasts.
  • Spotting or breakthrough bleeding: irregular light bleeding.
  • Weight change: slight increase or decrease.
  • Mood swings: emotional variability.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clots in deep veins.
  • Pulmonary embolism: clot migration to lungs.
  • Stroke or transient ischemic attack.
  • Myocardial infarction: heart attack risk.
  • Severe allergic reaction: rash, swelling, anaphylaxis.
  • Liver dysfunction: jaundice or abnormal liver enzymes.

Precautions & Warnings

  • Before prescribing Liana, clinicians should evaluate individual risk factors and contraindications.
  • Assess cardiovascular risk: avoid in women with history of thromboembolic disease.
  • Screen for smoking status: contraindicated in smokers over 35 years.
  • Avoid use in pregnancy: product is classified as pregnancy category X.
  • Consider hepatic function: liver disease may alter drug metabolism.
  • Monitor blood pressure regularly during therapy.
  • Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Liana can interact with several medicines, affecting efficacy or safety.

Major Interactions (Avoid)

  • Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): markedly reduce contraceptive effectiveness.
  • Rifampin: decreases hormone levels, increasing risk of unintended pregnancy.
  • Certain HIV protease inhibitors (e.g., ritonavir): may heighten risk of thrombotic events.

Moderate Interactions (Monitor Closely)

  • Broad‑spectrum antibiotics (e.g., tetracycline): may slightly diminish contraceptive reliability.
  • St. John’s Wort: herbal inducer that can lower hormone concentrations.
  • Selective serotonin reuptake inhibitors (e.g., fluoxetine): may increase hormone exposure, requiring monitoring.

Frequently Asked Questions

Liana is a combined oral contraceptive containing ethinylestradiol and levonorgestrel. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation, thickening cervical mucus, and altering the uterine lining to reduce the chance of implantation.

Ethinylestradiol, the estrogen component, suppresses the release of follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, stabilizing the endometrial lining and supporting the progestin’s contraceptive effect.

The dosing regimen for Liana is determined by the prescribing healthcare professional. Typically, combined oral contraceptives are taken once daily for a defined cycle, but the exact schedule and tablet strength must be confirmed by the prescriber.

Liana is classified as pregnancy category X, meaning it must not be used during pregnancy because it can harm the fetus. It is also generally not recommended while breastfeeding unless specifically advised by a qualified clinician.

To order Liana, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Liana contains the standard dose combination of ethinylestradiol and levonorgestrel, which is comparable to many other combined oral contraceptives on the market. Its efficacy, safety profile, and side‑effect spectrum are similar to other products that use the same hormone pair, though individual tolerability may vary.

Liana tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect them from excess moisture, direct sunlight, and keep them out of reach of children to maintain product integrity.

Liana is taken orally, usually once each day at the same time, as directed by the prescriber. The tablets are swallowed whole with water and should be started according to the clinician’s schedule, often on the first day of the menstrual period.

The most serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, and severe allergic reactions. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should avoid using Liana.

Liana is contraindicated in women who are pregnant, have known or suspected estrogen‑dependent tumors, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or who smoke cigarettes and are older than 35 years.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.